 | Figure 1: The effect of different intracellular concentrations of the Ca2+ chelator BAPTA on the ability of D2S and D2L receptor activation to reduce the whole-cell K+ current present in NG108-15 cells. BAPTA was varied in the patch pipette at the concentrations shown and allowed to dialyze into the cell for at least 4 minutes after formation of the whole-cell patch configuration . Each data point represents the mean (+SEM) percent reduction in peak outward current observed at a test membrane potential of +70 mV (holding potential was -60 mV) and in the presence of the D2 receptor agonist QUIN (20 micromolar). It may be observed that the ability of D2S, but not D2L , receptor stimulation to decrease whole-cell K+ current was attenuated by increases in intracellular BAPTA concentration. *p<0.05, analysis of variance and Bonferroni t-test
|
 | Figure 2: The effects on alterations in [Ca2+]i on the coupling of D2L receptors to whole-cell K+ current. It may be seen that bath application of ryanodine (RYAN 20 micromolar, left panel) or thapsigargin (THAPS 50 micromolar, right panel) had no effect on the K+ current observed in this cells. The inset whole-cell current and voltage traces are representative traces from a single cell in both treatment conditions. The cells were held at a membrane potential of -60 mV and stepped to a test potential of +70 mV for a duration of 300 msec. Data represents the mean +SEM for the individual cells studied (N=7 for both groups). Current trace calibration bar represents 1000 pA.
|
 | Figure 3: Bar graph illustrating the effect of bath application of the D2 receptor agonists quinpirole (QUIN) on [Ca2+]i in transfected NG108-15 cells. It may be observed that in NG108-15 cells stably expressing either the D2L or the D2S receptor, QUIN application (50 micromolar) produced an increase in [Ca2+]i relative to control (C). In contrast, there was no effect of QUIN application on wild-type cells. Each bar represents the mean +SEM [Ca2+]i calculated for the group (number above each bar represents the number of cells sampled). *p<0.05, analysis of variance and Bonferroni t-test.
|
 | Figure 4: Photomicrographs demonstrating the mobilization of intracellular calcium upon stimulation of D2L receptors stably expressed in NG108-15 cells. The pictures represent pseudocolor images of the ratio of the fluorescence intensity measured at 340 and 380 nm. The top panel show the resting calcium levels in several NG108-15 cells. The bottom panel shows the same cells two minutes after bath application of the D2 receptor agonist quinpirole (20 micromolar). It may be observed that every cell in the field studied demonstrated an increase in [Ca2+]i as indicated by a shift in color from blue towards yellow-red (the relative concentration of calcium is indicated by the calibration bar, see text for details).
|
 | Figure 5: Bar graph illustrating the ability of ryanodine to block the increase in [Ca2+]i which normally accompanies stimulation of D2 receptors. In both D2L and D2S expressing NG108-15 cells QUIN application (50 micromolar) produced a significant increase in [Ca2+]i relative to control levels (C). Ryanodine blocked the observed increase in both transfected groups (RYAN + QUIN). Each bar represents the mean +SEM [Ca2+]i calculated for the group (number above each bar represents the number of cells sampled). *p<0.05, analysis of variance and Bonferroni t-test.
|
 | Figure 6: Bar graph illustrating the ability of pertussis toxin pretreatment to block the increase in [Ca2+]i which normally accompanies stimulation of D2S receptors. In both D2L and D2S expressing NG108-15 cells QUIN application (50 micromolar) produced a significant increase in [Ca2+]i relative to control levels (C). Pretreatment with pertussis toxin (PTX + QUIN) blocked the observed increase in D2S but not D2L transfected NG108-15 cells. Each bar represents the mean +SEM [Ca2+]i calculated for the group (number above each bar represents the number of cells sampled). *p<0.05, analysis of variance and Bonferroni t-test.
|